Sartorius Stedim Biotech SA
PAR:DIM

Watchlist Manager
Sartorius Stedim Biotech SA Logo
Sartorius Stedim Biotech SA
PAR:DIM
Watchlist
Price: 212.8 EUR 0.61% Market Closed
Market Cap: 20.7B EUR

Intrinsic Value

The intrinsic value of one DIM stock under the Base Case scenario is 178.4 EUR. Compared to the current market price of 212.8 EUR, Sartorius Stedim Biotech SA is Overvalued by 16%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

DIM Intrinsic Value
178.4 EUR
Overvaluation 16%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Sartorius Stedim Biotech SA

DIM
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for DIM cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Sartorius Stedim Biotech SA
PAR:DIM
FR
Life Sciences Tools & Services
Market Cap
20.7B EUR
IPO
Oct 20, 1994
FR
Life Sciences Tools & Services
Market Cap
20.7B EUR
IPO
Oct 20, 1994
Price
€false
EPS
€false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Sartorius Stedim Biotech SA
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Sartorius Stedim Biotech SA

Current Assets 1.8B
Cash & Short-Term Investments 727m
Receivables 296.4m
Other Current Assets 756.6m
Non-Current Assets 6.5B
Long-Term Investments 23.7m
PP&E 1.9B
Intangibles 4.5B
Other Non-Current Assets 72.1m
Efficiency

Free Cash Flow Analysis
Sartorius Stedim Biotech SA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Sartorius Stedim Biotech SA

Revenue
2.9B EUR
Cost of Revenue
-1.6B EUR
Gross Profit
1.3B EUR
Operating Expenses
-852.8m EUR
Operating Income
401.5m EUR
Other Expenses
-197.2m EUR
Net Income
204.3m EUR
Fundamental Scores

DIM Profitability Score
Profitability Due Diligence

Sartorius Stedim Biotech SA's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROE
Positive Free Cash Flow
Positive Operating Income
52/100
Profitability
Score

Sartorius Stedim Biotech SA's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

DIM Solvency Score
Solvency Due Diligence

Sartorius Stedim Biotech SA's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
47/100
Solvency
Score

Sartorius Stedim Biotech SA's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DIM Price Targets Summary
Sartorius Stedim Biotech SA

Wall Street analysts forecast DIM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DIM is 252.72 EUR with a low forecast of 202 EUR and a high forecast of 325.5 EUR.

Lowest
Price Target
202 EUR
5% Downside
Average
Price Target
252.72 EUR
19% Upside
Highest
Price Target
325.5 EUR
53% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for DIM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

DIM Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one DIM stock?

The intrinsic value of one DIM stock under the Base Case scenario is 178.4 EUR.

Is DIM stock undervalued or overvalued?

Compared to the current market price of 212.8 EUR, Sartorius Stedim Biotech SA is Overvalued by 16%.

Back to Top